Medical News

Clint Spiegel, PhD, Assistant Professor of Chemistry at Western Washington University in Bellingham, has been awarded a three-year, $390,000 grant from the National Institutes of Health (NIH) to research potential new therapies for hemophilia A.

Ample supplies of the H1N1 vaccine have now been shipped to states, according to the Centers for Disease Control and Prevention (CDC), so it is no longer reporting on the status of state supplies or orders shipped.

The National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health, awarded two research grants to The Children’s Hospital of Philadelphia (CHOP).

Scientists from the Imperial College of London (ICL) may have uncovered a potential new way to regulate blood clotting, especially important for people with deep vein thromboses, blood clots in the legs, or hemophilia.

Latest reports from the CDC indicate that H1N1 flu activity in the U.S. is low; it is elevated in only one region, the Southeast.

A cooperative effort by researchers from the U.S. and the United Kingdom (UK) to develop a gene therapy for hemophilia B has resulted in a new phase of clinical development.

The U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have announced that both agencies have agreed to accept the submission of a single annual report from sponsors of orphan drugs and biologics.

Researchers at the Mayo Clinic (MC) in Rochester, MN, published a retrospective study in March of circumcision in patients with bleeding disorders. The purpose of the study was to examine the outcomes of circumcisions performed on patients who were evaluated at MC to determine the extent of related complications and create guidelines for clinical management.